HUYABIO International
Jerome Riebman, MD, MA has extensive experience in the medical and pharmaceutical industry, having held various leadership roles in companies such as HUYABIO International, Bay Innovation Group, Aziyo Biologics, Amgen, Novartis Pharmaceuticals, Johnson & Johnson, and Ethicon. With a background in surgery and academic positions at Western University of Health Sciences and Stanford University School of Medicine, Jerome has a wealth of experience in clinical development, medical affairs, and regenerative medicine. Their expertise and leadership have contributed to the advancement of therapeutic solutions in areas such as cardiology, orthopedics, and heart failure.
This person is not in the org chart
This person is not in any offices
HUYABIO International
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.